The lawsuits, which allege violations of the federal racketeering laws, accused merck and schering-plough of engaging in a scheme to suppress 2006 results of clinical studies in order to prolong billions of dollars in annual sales expected to be lost with the expiration of merck s patent for the blockbuster cholesterol drug, zocor, a statin.

Read More